Skip to main content
logo
AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
13.17
0.00 (0.00%)
At close: Aug 31, 2026, 4:00 PM EDT
13.07
-0.10 (-0.76%)
After-hours: Aug 31, 2026, 7:30 PM EDT

AgomAb Therapeutics NV Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Net Income
-66.65-62.55-46.27-11.39-8.14-
Depreciation & Amortization
0.20.220.310.10.02-
Stock-Based Compensation
5.235.361.072.162.21-
Other Operating Activities
2.524.83-0.66-19.58-14.47-
Change in Accounts Payable
4.052.36-0.233.692.95-
Change in Unearned Revenue
0.430.75-0.4-0.581.45-
Change in Other Net Operating Assets
-2.5-2.7-0.661.01-2.99-
Operating Cash Flow
-56.73-51.74-46.83-24.59-18.97-
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Capital Expenditures
-0-0-0.68---
Cash Acquisitions
--3---4.59-
Investment in Securities
-30-30-40-40-
Investing Cash Flow
-30-33-0.6840-44.59-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Long-Term Debt Issued
----0.14-
Long-Term Debt Repaid
--0.34-0.16-0.1-0.72-
Net Debt Issued (Repaid)
-0.34-0.34-0.16-0.1-0.58-
Issuance of Common Stock
163.96-97.0679.8738.39-
Other Financing Activities
1.27--0.13-0.45-0.17-
Financing Cash Flow
164.9-0.3496.7679.3237.63-

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Foreign Exchange Rate Adjustments
0.050.05-0.2---
Net Cash Flow
78.21-85.0449.0694.73-25.92-

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Free Cash Flow
-56.73-51.75-47.5-24.59-18.97-
Free Cash Flow Growth
------
Free Cash Flow Per Share
-2.75-95.63-87.78-45.45-35.05-
Levered Free Cash Flow
--24.37-16.51-49.9--
Unlevered Free Cash Flow
--24.33-16.47-49.88--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Cash Interest Paid
0.10.070.010.020.04-
Cash Income Tax Paid
--000-
Change in Working Capital
1.980.41-1.284.121.41-
SEC Filings: 10-K · 10-Q